Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 20, 2001
Grant Date -
N/A
app pub date -
Jun 14, 1999
filing date -
Jun 22, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates in particular to a combination product comprising at least one compound with affinity for the mitochondrial benzodiazepine receptor, and to at least one apoptosis-inducing agent for simultaneous or separate use or for use spread out over time, which is intended for the treatment of cancer. Another aspect of the present invention relates to the use of the said compound and/or of the said combination product for the manufacture of a medicinal product intended to facilitate the induction of apoptosis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully